eFFECTOR Therapeutics (EFTR) Financial Statements

Price: $0.0002
Market Cap: $941
Avg Volume: 920
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.432
52W Range: $0.0001-2.34
Website: eFFECTOR Therapeutics

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of eFFECTOR Therapeutics.


Income Statement

Revenue
Cost of Revenue
Revenue and Costs$50.00M$50.00M$40.00M$40.00M$30.00M$30.00M$20.00M$20.00M$10.00M$10.00M$0.00$0.0020202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Operating Expenses
Operating Income
Operating Expenses & Income$40.00M$40.00M$20.00M$20.00M$0.00$0.00-$20.00M-$20.00M-$40.00M-$40.00M20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Revenue $- $3.55M $1.43M $42.00M $-
Cost of Revenue $111.00K $53.00K $24.00K $21.83M $307.00K
Gross Profit $-22.92M $3.50M $1.41M $20.17M $-307.00K
Gross Profit Ratio - 98.51% 98.32% 48.02% -
Research and Development Expenses $22.92M $23.31M $19.96M $21.83M $23.58M
General and Administrative Expenses $10.93M $12.64M $13.37M $4.35M $4.71M
Selling and Marketing Expenses $- $- $- $- $-
Selling General and Administrative Expenses $10.93M $12.64M $13.37M $4.35M $4.71M
Other Expenses $- $-3.55M $-1.43M $9.00K $-
Operating Expenses $33.84M $32.40M $31.90M $26.18M $28.30M
Cost and Expenses $33.84M $32.40M $31.90M $26.18M $28.61M
Interest Income $1.95M $439.00K $6.00K $67.00K $239.00K
Interest Expense $- $2.25M $1.76M $1.33M $1.38M
Depreciation and Amortization $111.00K $53.00K $24.00K $160.00K $307.00K
EBITDA $-33.73M $-32.40M $-31.90M $16.05M $-28.30M
EBITDA Ratio - -911.99% -2230.56% 38.23% -
Operating Income $-33.84M $-32.40M $-31.90M $15.82M $-28.61M
Operating Income Ratio - -911.99% -2230.56% 37.66% -
Total Other Income Expenses Net $-1.97M $9.74M $47.70M $-1.26M $-1.13M
Income Before Tax $-35.81M $-22.66M $15.80M $14.56M $-29.74M
Income Before Tax Ratio - -637.91% 1104.76% 34.67% -
Income Tax Expense $- $-9.74M $-24.00K $351.00K $135.14K
Net Income $-35.81M $-12.93M $15.80M $14.21M $-29.74M
Net Income Ratio - -363.83% 1104.76% 33.84% -
EPS $-16.37 $-7.85 $9.78 $23.74 $-53.83
EPS Diluted $-16.37 $-7.85 $9.78 $23.74 $-53.83
Weighted Average Shares Outstanding 2.19M 1.65M 1.62M 598.56K 552.43K
Weighted Average Shares Outstanding Diluted 2.19M 1.65M 1.62M 598.56K 552.43K
SEC Filing Source Source Source Source Source

Balance Sheet

Total Assets
Total Liabilities
Total Assets and Liabilities$160.00M$160.00M$120.00M$120.00M$80.00M$80.00M$40.00M$40.00M$0.00$0.0020202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Equity$40.00M$40.00M$0.00$0.00-$40.00M-$40.00M-$80.00M-$80.00M-$120.00M-$120.00M-$160.00M-$160.00M20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents $14.88M $8.71M $49.70M $15.22M $3.43M
Short Term Investments $3.50M $17.60M $- $- $-
Cash and Short Term Investments $18.37M $26.31M $49.70M $15.22M $3.43M
Net Receivables $- $- $- $- $-
Inventory $- $-27.00K $-100.00K $- $-
Other Current Assets $1.47M $1.70M $6.39M $2.72M $845.00K
Total Current Assets $19.84M $28.01M $52.90M $16.58M $4.27M
Property Plant Equipment Net $193.00K $352.00K $257.00K $126.00K $823.00K
Goodwill $- $- $- $- $-
Intangible Assets $- $- $- $- $-
Goodwill and Intangible Assets $- $- $- $- $-
Long Term Investments $- $- $- $- $-
Tax Assets $- $- $- $- $-
Other Non-Current Assets $513.00K $711.00K $903.00K $-126.00K $-823.00K
Total Non-Current Assets $706.00K $1.06M $1.16M $126.00K $823.00K
Other Assets $- $- $- $- $1
Total Assets $20.54M $29.08M $54.06M $16.70M $5.09M
Account Payables $2.33M $1.49M $516.00K $347.00K $598.00K
Short Term Debt $20.55M $20.22M $88.00K $6.01M $15.24M
Tax Payables $- $463.00K $351.00K $351.00K $-
Deferred Revenue $- $- $- $1.98M $-
Other Current Liabilities $2.92M $2.90M $3.02M $2.07M $3.09M
Total Current Liabilities $25.80M $25.07M $3.98M $8.78M $18.93M
Long Term Debt $- $120.00K $19.99M $6.95M $-
Deferred Revenue Non-Current $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $-
Other Non-Current Liabilities $543.00K $-14.00K $12.81M $133.22M $-
Total Non-Current Liabilities $543.00K $106.00K $32.79M $140.17M $-
Other Liabilities $- $- $- $- $-
Total Liabilities $26.34M $25.18M $36.77M $148.95M $18.93M
Preferred Stock $- $- $54.06M $133.22M $133.22M
Common Stock $- $4.00K $4.00K $1.00K $1.00K
Retained Earnings $-179.38M $-143.57M $-120.90M $-136.70M $-150.91M
Accumulated Other Comprehensive Income Loss $- $-18.00K $-54.06M $-133.22M $-999
Other Total Stockholders Equity $173.58M $147.48M $192.24M $137.68M $3.85M
Total Stockholders Equity $-5.79M $3.90M $17.28M $-132.25M $-13.84M
Total Equity $-5.79M $3.90M $17.28M $-132.25M $-13.84M
Total Liabilities and Stockholders Equity $20.54M $29.08M $54.06M $16.70M $5.09M
Minority Interest $- $- $- $- $-
Total Liabilities and Total Equity $20.54M $29.08M $54.06M $16.70M $5.09M
Total Investments $3.50M $17.60M $- $- $-
Total Debt $20.55M $20.28M $20.03M $12.96M $15.24M
Net Debt $5.67M $11.57M $-29.67M $-2.25M $11.82M

Cash Flow Statement

Operating Cash Flow
Investing Cash Flow
Operating and Investing Cash Flow$20.00M$20.00M$10.00M$10.00M$0.00$0.00-$10.00M-$10.00M-$20.00M-$20.00M-$30.00M-$30.00M20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Financing Cash Flow$60.00M$60.00M$40.00M$40.00M$20.00M$20.00M$0.00$0.00-$20.00M-$20.00M20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Net Income $-35.81M $-22.66M $15.80M $14.21M $-29.74M
Depreciation and Amortization $111.00K $53.00K $24.00K $160.00K $307.00K
Deferred Income Tax $- $- $-539.00K $-333.00K $-1.99M
Stock Based Compensation $4.59M $5.33M $8.66M $499.00K $646.00K
Change in Working Capital $1.69M $2.68M $-238.00K $-824.00K $1.07M
Accounts Receivables $- $- $- $- $-
Inventory $- $- $- $- $-
Accounts Payables $855.00K $958.00K $155.00K $-251.00K $-727.00K
Other Working Capital $830.00K $1.72M $-393.00K $-573.00K $1.80M
Other Non Cash Items $-130.00K $-11.30M $-48.59M $122.00K $2.10M
Net Cash Provided by Operating Activities $-29.55M $-25.90M $-24.89M $13.84M $-27.60M
Investments in Property Plant and Equipment $-97.00K $-192.00K $-42.00K $-154.00K $-4.00K
Acquisitions Net $- $17.67M $607.00K $- $88.00K
Purchases of Investments $-17.17M $-52.42M $- $- $-
Sales Maturities of Investments $31.75M $34.75M $- $- $-
Other Investing Activities $- $-17.67M $607.00K $- $88.00K
Net Cash Used for Investing Activities $14.48M $-17.86M $565.00K $-154.00K $84.00K
Debt Repayment $- $- $5.89M $-2.00M $-
Common Stock Issued $21.18M $2.80M $56.00K $108.00K $20.33M
Common Stock Repurchased $- $- $- $- $-86.00K
Dividends Paid $- $- $- $- $-
Other Financing Activities $56.00K $-34.00K $52.91M $108.00K $20.24M
Net Cash Used Provided by Financing Activities $21.23M $2.77M $58.81M $-1.89M $20.24M
Effect of Forex Changes on Cash $- $- $- $- $10.70M
Net Change in Cash $6.17M $-40.99M $34.49M $11.79M $3.43M
Cash at End of Period $14.88M $8.71M $49.70M $15.22M $3.43M
Cash at Beginning of Period $8.71M $49.70M $15.22M $3.43M $-
Operating Cash Flow $-29.55M $-25.90M $-24.89M $13.84M $-27.60M
Capital Expenditure $-97.00K $-192.00K $-42.00K $-154.00K $-4.00K
Free Cash Flow $-29.65M $-26.09M $-24.93M $13.68M $-27.60M